Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,657 Endocrine
clinical trials

Endocrinology Clinical Trial
Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas
Status: Upcoming
Updated: 12/31/1969
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Endocrinology, Pulmonary / Respiratory Diseases Clinical Trial
Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis
Status: Upcoming, Phase I
Updated: 12/31/1969
mi
from
Portland, OR
Click here to add this to my saved trials
Endocrinology Clinical Trial
Contrasting Ketogenic and Mediterranean Diets in Individuals With Type 2 Diabetes and Prediabetes: The Keto-Med Trial
Status: Upcoming
Updated: 12/31/1969
mi
from
Stanford, CA
Click here to add this to my saved trials
Endocrinology, Rheumatology Clinical Trial
One Week Comparison Study of PTH and PTHrP Infusions
Status: Upcoming, Phase I
Updated: 4/25/2014
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Endocrinology, Immunology / Infectious Diseases Clinical Trial
Diabetes Islet Preservation Immune Treatment
Status: Upcoming, Phase I, II
Updated: 12/31/1969
mi
from
Miami, FL
Click here to add this to my saved trials
Endocrinology, Other Clinical Trial
Measurement of Glucose Metabolism in Humans: Effect of Recurrent Hypoglycemia on Hypothalamic GABA
Status: Upcoming, Phase I
Updated: 12/31/1969
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Congenital Adrenal Hyperplasia Clinical Trial
Androgen Reduction in Congenital Adrenal Hyperplasia
Status: Upcoming, Phase II
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Congenital Adrenal Hyperplasia Clinical Trial
Androgen Reduction in Congenital Adrenal Hyperplasia
Status: Upcoming, Phase II
Updated: 12/31/1969
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Hypoglycemia Unawareness Clinical Trial
Carvedilol in Treating Hypoglycemia Unawareness
Status: Upcoming, Phase II
Updated: 12/31/1969
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Hyperinsulinemic Hypoglycemia Clinical Trial
Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery
Status: Upcoming, Phase II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Understanding the Roles of Hormones in Adipocyte Remodeling Following Menopause
Status: Upcoming, Phase
Updated: 12/31/1969
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Phenylketonuria Clinical Trial
Liver Cell Transplant for Phenylketonuria
Status: Upcoming, Phase I, II
Updated: 12/31/1969
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phenylketonuria Clinical Trial
Liver Cell Transplant for Phenylketonuria
Status: Upcoming, Phase I, II
Updated: 12/31/1969
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism
Status: Upcoming
Updated: 2/25/2015
mi
from
Chicago, IL
Click here to add this to my saved trials
Endocrinology Clinical Trial
Clinical Utility of SUDOSCAN in the Pediatric Population
Status: Upcoming
Updated: 8/11/2014
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Congenital Adrenal Hyperplasia Clinical Trial
Androgen Reduction in Congenital Adrenal Hyperplasia
Status: Upcoming, Phase II
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Endocrinology, Pharmacology / Toxicology Clinical Trial
Vitamin D Homeostasis in Sarcoidosis
Status: Upcoming, Phase IV
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Glycogen Storage Disease Type I Clinical Trial
Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I
Status: Upcoming, Phase
Updated: 12/31/1969
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Glucose Homeostasis in Pseudohypoparathyroidism
Status: Upcoming, Phase
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Endocrinology Clinical Trial
CGM/Clarity Use, Glycemic Control and Clinical Outcomes
Status: Upcoming, Phase II, III
Updated: 12/31/1969
mi
from
Baltimore, MD
Click here to add this to my saved trials
Endocrinology, Immunology / Infectious Diseases Clinical Trial
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials
Endocrinology Clinical Trial
Pompe Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Dublin, OH
Click here to add this to my saved trials
Endocrinology Clinical Trial
Pompe Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Morristown, NJ
Click here to add this to my saved trials
Endocrinology Clinical Trial
Pompe Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Paterson, NJ
Click here to add this to my saved trials
Endocrinology, Neurology, Other Clinical Trial
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials
Primary Immune Deficiency Clinical Trial
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Ankara,
Click here to add this to my saved trials
Endocrinology, Neurology, Pharmacology / Toxicology Clinical Trial
International Collaborative Gaucher Group (ICGG) Gaucher Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Dublin, OH
Click here to add this to my saved trials
Endocrinology, Neurology, Pharmacology / Toxicology Clinical Trial
International Collaborative Gaucher Group (ICGG) Gaucher Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Morristown, NJ
Click here to add this to my saved trials
Endocrinology, Neurology, Pharmacology / Toxicology Clinical Trial
International Collaborative Gaucher Group (ICGG) Gaucher Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Paterson, NJ
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
mi
from
Haddon Heights, NJ
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
mi
from
Levittown, PA
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
mi
from
Lexington, KY
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
mi
from
Monroe, NC
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
mi
from
Richmond, VA
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
mi
from
Tustin, CA
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
mi
from
West Hills, CA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Lysosomal Acid Lipase (LAL) Deficiency Registry
Status: Enrolling, Phase
Updated: 3/1/2018
mi
from
Providence, RI
Click here to add this to my saved trials
Medullary Thyroid Cancer Clinical Trial
Expanded Access of Cabozantinib in Medullary Thyroid Cancer
Status: Enrolling
Updated: 11/6/2012
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Chronic Hypoparathyroidism Clinical Trial
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Chronic Hypoparathyroidism Clinical Trial
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Graz,
Click here to add this to my saved trials
Secondary Hypogonadism Clinical Trial
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
Status: Enrolling, Phase III
Updated: 1/16/2014
mi
from
Cleveland, OH
Click here to add this to my saved trials
Secondary Hypogonadism Clinical Trial
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
Status: Enrolling, Phase III
Updated: 1/16/2014
mi
from
Houston, TX
Click here to add this to my saved trials
Hypophosphatasia HPP Clinical Trial
Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)
Status: Enrolling
Updated: 4/2/2014
mi
from
Springfield, MO
Click here to add this to my saved trials
Refractory Hurthle Cell Thyroid Cancer Clinical Trial
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Commack, NY
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
mi
from
Atlanta, GA
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
mi
from
Bronx, NY
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
mi
from
Chicago, IL
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
mi
from
Greenville, NC
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling, Phase III
Updated: 3/30/2016
mi
from
Wilmington, DE
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
mi
from
Neptune, NJ
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Differentiated Thyroid Cancer Clinical Trial
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Status: Enrolling
Updated: 3/15/2016
mi
from
Washington DC,
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
'Aiea, HI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Annandale, VA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Appleton, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ashland, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Austin, TX
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bayamon,
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlingame, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Caro, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Clovis, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Collegeville, PA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, MS
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Dearborn, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Decatur, IL
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Franklin, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fremont, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Garden City, KS
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Georgetown, SC
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Germantown, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Great Bend, KS
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Honolulu, HI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Huntersville, NC
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Lake Success, NY
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Lebanon, PA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Livonia, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
London, KY
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Marinette, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Maryville, TN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Mayfield Heights, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Middletown, NJ
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Monticello, MN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Newburgh, IN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Novi, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Omaha, NE
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ontario, OR
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Pahrump, NV
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Port Huron, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Port Royal, SC
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Rhinelander, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Riverton, UT
Click here to add this to my saved trials
1 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37